| |
Management and Administration
Hugh Hoogendoorn
President
Patricia Hoogendoorn
Chief Financial Officer
David Moreno
Business & Marketing Manager
Marilyn Johnston, MLT, ART
Consultant
Dr. Mark Crowther, M.D.
Medical Director
Brandon Johnston, B. Sc
Quality Assurance Specialist
Joanne McGrath, MLT
Laboratory Services Manager
Gaspare Mattina, B. Eng
Information Technology
Laboratory Team
Franca Angeloni, MLT
Nancy McEwen, MLT
Eman Ali, MLT, B.App.Sc.
Penny Joshua, B.Sc., CMLA
Mala Rupwate, MLT, ART, B.Sc.
Nidhi Jain, Ph.D
|
|
 |
NOW AVAILABLE!!
Microparticle Activity Analysis
For more information see our News and Upcoming Events page.
Genotyping for Warfarin Therapy Cytochrome
P450 2C9 gene (CYP2C9) & Vitamin K Epoxide Reductase Complex 1 gene (VKORC1) genotyping is now available. For more information see our News and Upcoming Events page.
XXII Congress of the International
Society on Thrombosis and
Haemostasis
The XXII ISTH Congress is to be held in Boston from July 11 to 16, 2009. Marilyn Johnston has had two abstracts accepted for poster presentation and publication. For more information see our News and Upcoming Events page.
Molecular Cancer Therapeutics
Article
HRL is pleased to inform of a publication by
Lucy Shin, the recipient of the HRL Scholarship for 2006, titled "Effects of the chemotherapeutic agent doxorubicon on the protein C anticoagulant pathway". For more information see our News and Upcoming Events page.
PROCALCITONIN
Testing
The B·R·A·H·M·S PCT LIA assay has been cleared by the FDA for the early diagnosis of patients at risk for progression to severe sepsis.
HRL offers Procalcitonin (PCT) testing for research purposes. The clinical utility in select patient populations has already been identified and continued studies to discover the optimal utilization of this marker as it relates to patient management is foreseen. The availability of this FDA-cleared PCT
assay will encourage further international
clinical-scientific studies. Click here to view the News and Upcoming Events page.
|
|
|
|
